查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
CRISPR 和 cas 基因市场规模、市场份额、应用分析、区域展望、增长趋势、主要参与者、竞争战略和预测，2023-2031 年
市场调查报告书
商品编码
1283944

CRISPR 和 cas 基因市场规模、市场份额、应用分析、区域展望、增长趋势、主要参与者、竞争战略和预测，2023-2031 年

CRISPR And Cas Genes Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023 To 2031
出版日期: | 出版商: Acute Market Reports | 英文 120 Pages | 商品交期: 最快1-2个工作天内

价格

CRISPR 和 cas 基因簇已成为基因工程领域最有前途的工具之一，彻底改变了我们处理基因编辑和工程的方式。CRISPR/Cas 系统是细菌中一种天然存在的机制，使它们能够抵御入侵的病毒。该系统可以靶向和改变特定基因，使其成为研究和医学中的强大工具。全球 CRISPR 和 cas 基因簇市场预计在未来几年将显着增长，在 2023-2031 年的预测期内达到 18.5% 的复合年增长率。这种增长是由于农业、製药和生物技术等各种应用对基因编辑技术的需求不断增加。製药和生物技术行业对 CRISPR 和 cas 基因簇市场的增长做出了重大贡献。该技术有望治疗多种遗传疾病，并被用于药物发现和药物开发。农业也利用这项技术来提高作物产量和开发抗病作物。

製药行业对基因编辑技术的需求不断增长

製药行业是 CRISPR 和 cas 基因簇市场的主要驱动力。该技术有可能治疗多种遗传疾病，并被用于药物发现和药物开发。到2025年，全球基因编辑市场预计将达到95亿美元，而CRISPR/Cas系统是应用最广泛的基因编辑技术。包括 CRISPR Therapeutics AG、Intellia Therapeutics 和 Editas Medicine 在内的几家公司正在大力投资开发基于 CRISPR 的疗法。

在农业中采用 CRISPR/Cas 技术

农业部门也在推动 CRISPR 和 cas 基因簇市场的增长。该技术用于提高作物产量和开发抗病作物。到 2025 年，全球农业生物技术市场预计将超过 550 亿美元，而 CRISPR/Cas 系统是推动这一增长的关键技术之一。拜耳公司、杜邦先锋和陶氏杜邦等公司正在大力投资开发 CRISPR 编辑作物。

遗传病患病率上升

遗传性疾病患病率上升推动了对 CRISPR 和 cas 基因簇等基因编辑技术的需求。根据世界卫生组织 (WHO) 的数据，遗传病影响着全世界数百万人，估计每 20 个新生儿中就有 1 个患有遗传病。我在这里。CRISPR/Cas 系统具有治疗各种遗传疾病的潜力，例如镰状细胞性贫血、囊性纤维化和亨廷顿舞蹈病。多项临床试验正在进行中，以验证基于 CRISPR 的遗传病疗法的安全性和有效性，这可能会进一步推动 CRISPR 和 cas 基因簇市场的增长。

脱靶效应和伦理问题

CRISPR 和 cas 基因簇市场的主要製约因素之一是可能会导致意外和有害的基因组改变的脱靶效应。CRISPR/Cas 系统非常精确，但并不完美，脱靶效应的风险仍然存在。出于这个原因，人们担心使用这种技术进行基因编辑的安全性和伦理影响。此外，有人担心该技术可能会被滥用于非医疗目的，例如增强人类特征。这些担忧可能会导致监管审查力度加大和技术采用速度放缓，从而抑制 CRISPR 和 cas 基因簇市场的增长。

生物医药板块主导市场销售

CRISPR 和 cas 基因簇市场有望在生物医学和农业领域实现显着增长。就收入而言，由于药物发现和市场开发对基因编辑技术的高需求，生物医药板块预计将主导市场。2022年，生物医学板块将占据CRISPR和cas基因簇市场的最大份额，预计该板块在2023-2031年的预测期内也将主导市场。另一方面，由于对抗病和高产作物的需求不断增长，预计农业部门在预测期内的复合年增长率最高。CRISPR/Cas 系统用于开发具有理想性状的作物，例如增加产量、耐旱性和抗病性。包括Bayer AG和DowDuPont在内的几家公司已投入巨资开发 CRISPR 编辑的作物，这可能会进一步推动农业部门的增长。

生物技术和製药公司主导市场收入

CRISPR 和 cas 基因簇市场也按最终用途细分，包括生物技术和製药公司、学术和政府研究机构以及合同研究组织 (CRO)。由于药物发现和药物开发对基因编辑技术的高需求，预计生物技术和製药公司将在收入方面占据市场主导地位。到 2022 年，生物技术和製药公司将占据 CRISPR 和 cas 基因簇市场的最大份额。然而，由于生物技术和製药公司越来越多地外包临床前和临床研究活动，预计合同研究组织 (CRO) 部分在 2023 年至 2031 年的预测期内将实现最高复合年增长率。CRO 提供广泛的服务，包括药物发现和开发、临床试验和监管服务。CRISPR 和 cas 基因簇在临床前和临床研究活动中的使用有望增加，这可能会进一步推动 CRO 领域的发展。

北美仍然是世界领先者

由于该地区有几个主要参与者以及生物技术和製药行业对基因编辑技术的采用率很高，北美将在 2022 年占据最大的市场份额。然而，由于该地区对生物技术研究的投资不断增加以及遗传疾病的流行率不断上升，预计亚太地区的复合年增长率将最高。此外，该地区还有几家新兴的生物技术和製药公司，这可能会进一步推动市场增长。由于政府对基因组编辑研究的资助增加以及对转基因作物的需求增加，预计欧洲也将为市场的增长做出重大贡献。

预测期内市场竞争加剧

CRISPR 和 cas 基因簇市场竞争激烈，市场上有多家主要参与者。市场领导者包括 Thermo Fisher Scientific, Inc.、Editas Medicine, Inc.、CRISPR Therapeutics AG、Intellia Therapeutics, Inc. 和 Caribou Biosciences, Inc.。这些参与者正专注于战略合作、合作伙伴关係和併购，以扩大他们的市场影响力并加强他们的产品组合。例如，2020 年，Thermo Fisher Scientific 收购了领先的分子诊断和样品製备技术提供商 QIAGEN NV，以扩大其生命科学产品范围。Editas Medicine 还与生物技术和製药行业的主要参与者建立了多项合作伙伴关係，以推进 CRISPR 基因编辑技术。此外，一些主要参与者正在投资研发活动，以开发新的和创新的基因编辑技术。例如，CRISPR Therapeutics 正在开发针对多种遗传疾病的基于 CRISPR 的疗法组合，而 Intellia Therapeutics 正在开髮用于体内递送 CRISPR-Cas9 基因编辑技术的专有平台。。此外，这些公司正专注于为其基因编辑技术获得监管批准。例如，2019 年，CRISPR Therapeutics 和 Vertex Pharmaceuticals 获得 FDA 批准使用 CRISPR-Cas9 技术进行基因疗法治疗镰状细胞病。

目录

第一章 前言

  • 举报内容
    • 报告目的
    • 目标听众
    • 提供的主要产品
  • 市场细分
  • 调查方法
    • 第一阶段 - 二次调查
    • 第二阶段 - 初步调查
    • 第三阶段——专家评审
    • 先决条件
    • 采取的方法

第二章执行摘要

第三章 CRISPR 和 cas 基因市场：竞争分析

  • 主要厂商的市场定位
  • 供应商采用的策略
  • 重点产业战略
  • 等级分析：2022 年与 2031 年

第 4 章 CRISPR 和 cas 基因市场：宏观分析和市场动态

  • 介绍
  • CRISPR 和 cas 基因簇的全球市场价值 2021-2031
  • 市场动态
    • 市场驱动力
    • 市场製约因素
    • 主要问题
    • 主要机会
  • 促进因素和抑制因素的影响分析
  • 跷跷板分析

5. 2021-2031 年按产品分列的 CRISPR 和 cas 基因市场

  • 市场概况
  • 增长/利润分析：2022 年与 2031 年
  • 市场细分
    • 试剂盒和酶
      • 基于向量的 Cas
      • 无 DNA Ca
    • 图书馆
    • 设计工具
    • 抗体
    • 其他

6. 2021-2031 年按服务分列的 CRISPR 和 cas 基因市场

  • 市场概况
  • 增长/利润分析：2022 年与 2031 年
  • 市场细分
    • 细胞系工程
    • gRNA 的设计
    • 微生物基因编辑
    • DNA合成

7. 2021-2031 年按应用分列的 CRISPR 和 cas 基因市场

  • 市场概况
  • 增长/利润分析：2022 年与 2031 年
  • 市场细分
    • 生物医学
      • 基因组工程
      • 疾病模型研究
      • 功能基因组学
      • 表观遗传学
      • 其他
    • 农业

8. 2021-2031 年最终用途的 CRISPR 和 cas 基因市场

  • 市场概况
  • 增长/利润分析：2022 年与 2031 年
  • 市场细分
    • 生物技术和製药公司
    • 学术机构和政府研究机构
    • 合同研究组织 (CRO)

第 9 章北美 CRISPR 和 cas 基因簇市场 2021-2031

  • 市场概况
  • 2021-2031 年各产品的 CRISPR 和 cas 基因市场
  • 2021-2031 年各服务的 CRISPR 和 cas 基因市场
  • 2021-2031 年按应用分列的 CRISPR 和 cas 基因市场
  • 2021-2031 年最终用途的 CRISPR 和 cas 基因市场
  • CRISPR 和 cas 基因的区域市场 2021-2031
    • 北美
      • 美国
      • 加拿大
      • 其他北美

10.英国和欧盟CRISPR和cas基因簇市场2021-2031

  • 市场概况
  • 2021-2031 年各产品的 CRISPR 和 cas 基因市场
  • 按服务划分的 CRISPR 和 cas 基因市场 2021-2031
  • 2021-2031 年按应用分列的 CRISPR 和 cas 基因市场
  • 2021-2031 年最终用途的 CRISPR 和 cas 基因市场
  • CRISPR 和 cas 基因的区域市场 2021-2031
    • 英国和欧盟
      • 英国
      • 德国
      • 西班牙
      • 意大利
      • 法国
      • 欧洲其他地区

第 11 章亚太 CRISPR 和 cas 基因簇市场 2021-2031

  • 市场概况
  • 2021-2031 年各产品的 CRISPR 和 cas 基因市场
  • 按服务划分的 CRISPR 和 cas 基因市场 2021-2031
  • 2021-2031 年按应用分列的 CRISPR 和 cas 基因市场
  • 2021-2031 年最终用途的 CRISPR 和 cas 基因市场
  • CRISPR 和 cas 基因的区域市场 2021-2031
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 亚太其他地区

第 12 章拉丁美洲 CRISPR 和 cas 基因簇市场 2021-2031

  • 市场概况
  • 2021-2031 年各产品的 CRISPR 和 cas 基因市场
  • 按服务划分的 CRISPR 和 cas 基因市场 2021-2031
  • 2021-2031 年按应用分列的 CRISPR 和 cas 基因市场
  • 2021-2031 年最终用途的 CRISPR 和 cas 基因市场
  • CRISPR 和 cas 基因的区域市场 2021-2031
    • 拉丁美洲
      • 巴西
      • 墨西哥
      • 其他拉丁美洲地区

13中东和非洲CRISPR和cas基因簇市场2021-2031

  • 市场概况
  • 2021-2031 年各产品的 CRISPR 和 cas 基因市场
  • 按服务划分的 CRISPR 和 cas 基因市场 2021-2031
  • 2021-2031 年按应用分列的 CRISPR 和 cas 基因市场
  • 2021-2031 年最终用途的 CRISPR 和 cas 基因市场
  • CRISPR 和 cas 基因的区域市场 2021-2031
    • 中东/非洲
      • GCC
      • 非洲
      • 其他中东/非洲地区

第十四章公司简介

  • Thermo Fisher Scientific Inc.
  • Editas Medicine Inc.
  • CRISPR Therapeutics AG
  • Intellia Therapeutics Inc.
  • Caribou Biosciences Inc.
  • 其他
Product Code: 139592-05-23

CRISPR and Cas genes have become one of the most promising tools in the field of genetic engineering, revolutionizing the way we approach gene editing and genetic manipulation. The CRISPR/Cas system is a naturally occurring mechanism in bacteria that allows them to defend themselves against invading viruses. This system can be adapted to target and modify specific genes, making it a powerful tool in research and medicine. The global CRISPR and Cas genes market is expected to grow significantly in the coming years, with a CAGR of 18.5% during the forecast period of 2023 to 2031. This growth is driven by the increasing demand for gene editing technologies in various applications such as agriculture, pharmaceuticals, and biotechnology. The pharmaceutical and biotechnology industries are the major contributors to the growth of the CRISPR and Cas genes market. The technology is being used in drug discovery and development, with the potential to treat a wide range of genetic disorders. The agriculture industry is also adopting this technology to improve crop yields and develop disease-resistant crops.

Increasing Demand for Gene Editing Technologies in Pharmaceutical Industry

The pharmaceutical industry is a major driver of the CRISPR and Cas genes market. The technology is being used in drug discovery and development, with the potential to treat a wide range of genetic disorders. The global gene editing market is expected to reach $9.5 billion by 2025, with the CRISPR/Cas system being the most widely used gene editing technology. Several companies are investing heavily in the development of CRISPR-based therapies, including CRISPR Therapeutics AG, Intellia Therapeutics, and Editas Medicine, among others.

Adoption of CRISPR/Cas Technology in Agriculture

The agriculture industry is also driving the growth of the CRISPR and Cas genes market. The technology is being used to improve crop yields and develop disease-resistant crops. The global agricultural biotechnology market is expected to cross $55 billion by 2025, with the CRISPR/Cas system being one of the key technologies driving this growth. Companies such as Bayer AG, DuPont Pioneer, and DowDuPont are investing heavily in the development of CRISPR-edited crops.

Rising Prevalence of Genetic Disorders

The rising prevalence of genetic disorders is driving the demand for gene editing technologies such as CRISPR and Cas genes. According to the World Health Organization, genetic disorders affect millions of people worldwide, with an estimated 1 in 20 live births being affected by a genetic disorder. The CRISPR/Cas system has the potential to treat a wide range of genetic disorders, including sickle cell anemia, cystic fibrosis, and Huntington's disease, among others. Several clinical trials are underway to test the safety and efficacy of CRISPR-based therapies for genetic disorders, which could further drive the growth of the CRISPR and Cas genes market.

Off-Target Effects and Ethical Concerns

One of the major restraints of the CRISPR and Cas genes market is the potential for off-target effects, which can result in unintended and potentially harmful changes to the genome. While the CRISPR/Cas system is highly precise, it is not perfect, and there is still a risk of off-target effects. This has led to concerns about the safety and ethical implications of using this technology for gene editing. In addition, there are also concerns about the potential misuse of this technology for non-medical purposes, such as enhancing human traits. These concerns could lead to increased regulatory scrutiny and slower adoption of the technology, which could restrain the growth of the CRISPR and Cas genes market.

Biomedical Segment to Dominate the Market Revenues

The CRISPR and Cas genes market is expected to witness significant growth in both the biomedical and agriculture segments. In terms of revenue, the biomedical segment is expected to dominate the market due to the high demand for gene editing technologies in drug discovery and development. The biomedical segment accounted for the largest share of the CRISPR and Cas genes market in 2022, the segment is also expected to dominate the market during the forecast period of 2023 to 2031. On the other hand, the agriculture segment is expected to witness the highest CAGR during the forecast period, driven by the increasing demand for disease-resistant and high-yielding crops. The CRISPR/Cas system is being used to develop crops with desirable traits, such as increased yield, drought resistance, and disease resistance. Several companies, including Bayer AG and DowDuPont, are investing heavily in the development of CRISPR-edited crops, which could further drive the growth of the agriculture segment.

Biotechnology and Pharmaceutical Companies to Dominate the Market Revenues

The CRISPR and Cas genes market is also segmented by end-use, including biotechnology and pharmaceutical companies, academics and government research institutes, and contract research organizations (CROs). Biotechnology and pharmaceutical companies are expected to dominate the market in terms of revenue, owing to the high demand for gene editing technologies in drug discovery and development. The biotechnology and pharmaceutical companies segment accounted for the largest share of the CRISPR and Cas genes market in 2022. However, the highest CAGR during the forecast period of 2023 to 2031 is expected in the contract research organizations (CROs) segment, driven by the increasing outsourcing of preclinical and clinical research activities by biotechnology and pharmaceutical companies. CROs provide a wide range of services, including drug discovery and development, clinical trials, and regulatory services, among others. The use of CRISPR and Cas genes in preclinical and clinical research activities is expected to increase, which could further drive the growth of the CROs segment.

North America Remains as the Global Leader

North America accounted for the largest share of the market in 2022, owing to the presence of several key players in the region and the high adoption rate of gene editing technologies in the biotechnology and pharmaceutical industries. However, the highest CAGR is expected in the Asia-Pacific region, driven by the increasing investments in biotechnology research and the growing prevalence of genetic disorders in the region. The region is also home to several emerging biotechnology and pharmaceutical companies, which could further drive the growth of the market. Europe is also expected to contribute significantly to the growth of the CRISPR and Cas genes market, owing to the increasing government funding for genome editing research and the growing demand for genetically modified crops in the region.

Market Competition to Intensify during the Forecast Period

The CRISPR and Cas genes market is highly competitive, with several key players operating in the market. Some of the top players in the market include Thermo Fisher Scientific, Inc., Editas Medicine, Inc., CRISPR Therapeutics AG, Intellia Therapeutics, Inc., and Caribou Biosciences, Inc., among others. These players are focusing on strategic collaborations, partnerships, and mergers and acquisitions to expand their market presence and strengthen their product portfolios. For instance, in 2020, Thermo Fisher Scientific acquired QIAGEN N.V., a leading provider of molecular diagnostics and sample preparation technologies, to expand its life sciences offerings. In addition, Editas Medicine has entered into several collaborations with key players in the biotechnology and pharmaceutical industries to advance its CRISPR gene editing technology. Furthermore, several key players are investing in research and development activities to develop new and innovative gene editing technologies. For instance, CRISPR Therapeutics is developing a portfolio of CRISPR-based therapies for a wide range of genetic disorders, while Intellia Therapeutics is developing a proprietary platform for the in vivo delivery of CRISPR-Cas9 gene editing technology. Moreover, companies are also focusing on obtaining regulatory approvals for their gene editing technologies. For instance, in 2019, CRISPR Therapeutics and Vertex Pharmaceuticals received FDA approval for their gene therapy, which uses CRISPR-Cas9 technology to treat sickle cell disease.

Historical & Forecast Period

This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2031.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of CRISPR And Cas Genes market are as follows:

  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the CRISPR And Cas Genes market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Product

  • Kits & Enzymes
    • Vector-based Cas
    • DNA-free Cas
  • Libraries
  • Design Tool
  • Antibodies
  • Others

Service

  • Cell Line Engineering
  • gRNA Design
  • Microbial Gene Editing
  • DNA Synthesis

Application

  • Biomedical
    • Genome Engineering
    • Disease Model Studies
    • Functional Genomics
    • Epigenetics
    • Others
  • Agricultural

End-use

  • Biotechnology & Pharmaceutical Companies
  • Academics & Government Research Institutes
  • Contract Research Organizations (CROs)

Region Segment (2021-2031; US$ Million)

  • North America
    • U.S.
    • Canada
    • Rest of North America
  • UK and European Union
    • UK
    • Germany
    • Spain
    • Italy
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

Key questions answered in this report:

  • What are the key micro and macro environmental factors that are impacting the growth of CRISPR And Cas Genes market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2031.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the CRISPR And Cas Genes market?
  • Which is the largest regional market for CRISPR And Cas Genes market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving CRISPR And Cas Genes market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the CRISPR And Cas Genes market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global CRISPR And Cas Genes Market
  • 2.2. Global CRISPR And Cas Genes Market, By Product, 2022 (US$ Million)
  • 2.3. Global CRISPR And Cas Genes Market, By Service, 2022 (US$ Million)
  • 2.4. Global CRISPR And Cas Genes Market, By Application, 2022 (US$ Million)
  • 2.5. Global CRISPR And Cas Genes Market, By End-use, 2022 (US$ Million)
  • 2.6. Global CRISPR And Cas Genes Market, By Geography, 2022 (US$ Million)
  • 2.7. Attractive Investment Proposition by Geography, 2022

3. CRISPR And Cas Genes Market: Competitive Analysis

  • 3.1. Market Positioning of Key CRISPR And Cas Genes Market Vendors
  • 3.2. Strategies Adopted by CRISPR And Cas Genes Market Vendors
  • 3.3. Key Industry Strategies
  • 3.4. Tier Analysis 2022 Versus 2031

4. CRISPR And Cas Genes Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global CRISPR And Cas Genes Market Value, 2021 - 2031, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis

5. CRISPR And Cas Genes Market: By Product, 2021-2031, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 5.3. Market Segmentation
    • 5.3.1. Kits & Enzymes
      • 5.3.1.1. Vector-based Cas
      • 5.3.1.2. DNA-free Cas
    • 5.3.2. Libraries
    • 5.3.3. Design Tool
    • 5.3.4. Antibodies
    • 5.3.5. Others

6. CRISPR And Cas Genes Market: By Service, 2021-2031, USD (Million)

  • 6.1. Market Overview
  • 6.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 6.3. Market Segmentation
    • 6.3.1. Cell Line Engineering
    • 6.3.2. gRNA Design
    • 6.3.3. Microbial Gene Editing
    • 6.3.4. DNA Synthesis

7. CRISPR And Cas Genes Market: By Application, 2021-2031, USD (Million)

  • 7.1. Market Overview
  • 7.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 7.3. Market Segmentation
    • 7.3.1. Biomedical
      • 7.3.1.1. Genome Engineering
      • 7.3.1.2. Disease Model Studies
      • 7.3.1.3. Functional Genomics
      • 7.3.1.4. Epigenetics
      • 7.3.1.5. Others
    • 7.3.2. Agricultural

8. CRISPR And Cas Genes Market: By End-use, 2021-2031, USD (Million)

  • 8.1. Market Overview
  • 8.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 8.3. Market Segmentation
    • 8.3.1. Biotechnology & Pharmaceutical Companies
    • 8.3.2. Academics & Government Research Institutes
    • 8.3.3. Contract Research Organizations (CROs)

9. North America CRISPR And Cas Genes Market, 2021-2031, USD (Million)

  • 9.1. Market Overview
  • 9.2. CRISPR And Cas Genes Market: By Product, 2021-2031, USD (Million)
  • 9.3. CRISPR And Cas Genes Market: By Service, 2021-2031, USD (Million)
  • 9.4. CRISPR And Cas Genes Market: By Application, 2021-2031, USD (Million)
  • 9.5. CRISPR And Cas Genes Market: By End-use, 2021-2031, USD (Million)
  • 9.6.CRISPR And Cas Genes Market: By Region, 2021-2031, USD (Million)
    • 9.6.1.North America
      • 9.6.1.1. U.S.
        • 9.6.1.1.1. CRISPR And Cas Genes Market: By Product, 2021-2031, USD (Million)
        • 9.6.1.1.1. CRISPR And Cas Genes Market: By Service, 2021-2031, USD (Million)
        • 9.6.1.1.1. CRISPR And Cas Genes Market: By Application, 2021-2031, USD (Million)
        • 9.6.1.1.1. CRISPR And Cas Genes Market: By End-use, 2021-2031, USD (Million)
      • 9.6.1.2. Canada
        • 9.6.1.2.1. CRISPR And Cas Genes Market: By Product, 2021-2031, USD (Million)
        • 9.6.1.2.1. CRISPR And Cas Genes Market: By Service, 2021-2031, USD (Million)
        • 9.6.1.2.1. CRISPR And Cas Genes Market: By Application, 2021-2031, USD (Million)
        • 9.6.1.2.1. CRISPR And Cas Genes Market: By End-use, 2021-2031, USD (Million)
      • 9.6.1.3. Rest of North America
        • 9.6.1.3.1. CRISPR And Cas Genes Market: By Product, 2021-2031, USD (Million)
        • 9.6.1.3.1. CRISPR And Cas Genes Market: By Service, 2021-2031, USD (Million)
        • 9.6.1.3.1. CRISPR And Cas Genes Market: By Application, 2021-2031, USD (Million)
        • 9.6.1.3.1. CRISPR And Cas Genes Market: By End-use, 2021-2031, USD (Million)

10. UK and European Union CRISPR And Cas Genes Market, 2021-2031, USD (Million)

  • 10.1. Market Overview
  • 10.2. CRISPR And Cas Genes Market: By Product, 2021-2031, USD (Million)
  • 10.3. CRISPR And Cas Genes Market: By Service, 2021-2031, USD (Million)
  • 10.4. CRISPR And Cas Genes Market: By Application, 2021-2031, USD (Million)
  • 10.5. CRISPR And Cas Genes Market: By End-use, 2021-2031, USD (Million)
  • 10.6.CRISPR And Cas Genes Market: By Region, 2021-2031, USD (Million)
    • 10.6.1.UK and European Union
      • 10.6.1.1. UK
        • 10.6.1.1.1. CRISPR And Cas Genes Market: By Product, 2021-2031, USD (Million)
        • 10.6.1.1.1. CRISPR And Cas Genes Market: By Service, 2021-2031, USD (Million)
        • 10.6.1.1.1. CRISPR And Cas Genes Market: By Application, 2021-2031, USD (Million)
        • 10.6.1.1.1. CRISPR And Cas Genes Market: By End-use, 2021-2031, USD (Million)
      • 10.6.1.2. Germany
        • 10.6.1.2.1. CRISPR And Cas Genes Market: By Product, 2021-2031, USD (Million)
        • 10.6.1.2.1. CRISPR And Cas Genes Market: By Service, 2021-2031, USD (Million)
        • 10.6.1.2.1. CRISPR And Cas Genes Market: By Application, 2021-2031, USD (Million)
        • 10.6.1.2.1. CRISPR And Cas Genes Market: By End-use, 2021-2031, USD (Million)
      • 10.6.1.3. Spain
        • 10.6.1.3.1. CRISPR And Cas Genes Market: By Product, 2021-2031, USD (Million)
        • 10.6.1.3.1. CRISPR And Cas Genes Market: By Service, 2021-2031, USD (Million)
        • 10.6.1.3.1. CRISPR And Cas Genes Market: By Application, 2021-2031, USD (Million)
        • 10.6.1.3.1. CRISPR And Cas Genes Market: By End-use, 2021-2031, USD (Million)
      • 10.6.1.4. Italy
        • 10.6.1.4.1. CRISPR And Cas Genes Market: By Product, 2021-2031, USD (Million)
        • 10.6.1.4.1. CRISPR And Cas Genes Market: By Service, 2021-2031, USD (Million)
        • 10.6.1.4.1. CRISPR And Cas Genes Market: By Application, 2021-2031, USD (Million)
        • 10.6.1.4.1. CRISPR And Cas Genes Market: By End-use, 2021-2031, USD (Million)
      • 10.6.1.5. France
        • 10.6.1.5.1. CRISPR And Cas Genes Market: By Product, 2021-2031, USD (Million)
        • 10.6.1.5.1. CRISPR And Cas Genes Market: By Service, 2021-2031, USD (Million)
        • 10.6.1.5.1. CRISPR And Cas Genes Market: By Application, 2021-2031, USD (Million)
        • 10.6.1.5.1. CRISPR And Cas Genes Market: By End-use, 2021-2031, USD (Million)
      • 10.6.1.6. Rest of Europe
        • 10.6.1.6.1. CRISPR And Cas Genes Market: By Product, 2021-2031, USD (Million)
        • 10.6.1.6.1. CRISPR And Cas Genes Market: By Service, 2021-2031, USD (Million)
        • 10.6.1.6.1. CRISPR And Cas Genes Market: By Application, 2021-2031, USD (Million)
        • 10.6.1.6.1. CRISPR And Cas Genes Market: By End-use, 2021-2031, USD (Million)

11. Asia Pacific CRISPR And Cas Genes Market, 2021-2031, USD (Million)

  • 11.1. Market Overview
  • 11.2. CRISPR And Cas Genes Market: By Product, 2021-2031, USD (Million)
  • 11.3. CRISPR And Cas Genes Market: By Service, 2021-2031, USD (Million)
  • 11.4. CRISPR And Cas Genes Market: By Application, 2021-2031, USD (Million)
  • 11.5. CRISPR And Cas Genes Market: By End-use, 2021-2031, USD (Million)
  • 11.6.CRISPR And Cas Genes Market: By Region, 2021-2031, USD (Million)
    • 11.6.1.Asia Pacific
      • 11.6.1.1. China
        • 11.6.1.1.1. CRISPR And Cas Genes Market: By Product, 2021-2031, USD (Million)
        • 11.6.1.1.1. CRISPR And Cas Genes Market: By Service, 2021-2031, USD (Million)
        • 11.6.1.1.1. CRISPR And Cas Genes Market: By Application, 2021-2031, USD (Million)
        • 11.6.1.1.1. CRISPR And Cas Genes Market: By End-use, 2021-2031, USD (Million)
      • 11.6.1.2. Japan
        • 11.6.1.2.1. CRISPR And Cas Genes Market: By Product, 2021-2031, USD (Million)
        • 11.6.1.2.1. CRISPR And Cas Genes Market: By Service, 2021-2031, USD (Million)
        • 11.6.1.2.1. CRISPR And Cas Genes Market: By Application, 2021-2031, USD (Million)
        • 11.6.1.2.1. CRISPR And Cas Genes Market: By End-use, 2021-2031, USD (Million)
      • 11.6.1.3. India
        • 11.6.1.3.1. CRISPR And Cas Genes Market: By Product, 2021-2031, USD (Million)
        • 11.6.1.3.1. CRISPR And Cas Genes Market: By Service, 2021-2031, USD (Million)
        • 11.6.1.3.1. CRISPR And Cas Genes Market: By Application, 2021-2031, USD (Million)
        • 11.6.1.3.1. CRISPR And Cas Genes Market: By End-use, 2021-2031, USD (Million)
      • 11.6.1.4. Australia
        • 11.6.1.4.1. CRISPR And Cas Genes Market: By Product, 2021-2031, USD (Million)
        • 11.6.1.4.1. CRISPR And Cas Genes Market: By Service, 2021-2031, USD (Million)
        • 11.6.1.4.1. CRISPR And Cas Genes Market: By Application, 2021-2031, USD (Million)
        • 11.6.1.4.1. CRISPR And Cas Genes Market: By End-use, 2021-2031, USD (Million)
      • 11.6.1.5. South Korea
        • 11.6.1.5.1. CRISPR And Cas Genes Market: By Product, 2021-2031, USD (Million)
        • 11.6.1.5.1. CRISPR And Cas Genes Market: By Service, 2021-2031, USD (Million)
        • 11.6.1.5.1. CRISPR And Cas Genes Market: By Application, 2021-2031, USD (Million)
        • 11.6.1.5.1. CRISPR And Cas Genes Market: By End-use, 2021-2031, USD (Million)
      • 11.6.1.6. Rest of Asia Pacific
        • 11.6.1.6.1. CRISPR And Cas Genes Market: By Product, 2021-2031, USD (Million)
        • 11.6.1.6.1. CRISPR And Cas Genes Market: By Service, 2021-2031, USD (Million)
        • 11.6.1.6.1. CRISPR And Cas Genes Market: By Application, 2021-2031, USD (Million)
        • 11.6.1.6.1. CRISPR And Cas Genes Market: By End-use, 2021-2031, USD (Million)

12. Latin America CRISPR And Cas Genes Market, 2021-2031, USD (Million)

  • 12.1. Market Overview
  • 12.2. CRISPR And Cas Genes Market: By Product, 2021-2031, USD (Million)
  • 12.3. CRISPR And Cas Genes Market: By Service, 2021-2031, USD (Million)
  • 12.4. CRISPR And Cas Genes Market: By Application, 2021-2031, USD (Million)
  • 12.5. CRISPR And Cas Genes Market: By End-use, 2021-2031, USD (Million)
  • 12.6.CRISPR And Cas Genes Market: By Region, 2021-2031, USD (Million)
    • 12.6.1.Latin America
      • 12.6.1.1. Brazil
        • 12.6.1.1.1. CRISPR And Cas Genes Market: By Product, 2021-2031, USD (Million)
        • 12.6.1.1.1. CRISPR And Cas Genes Market: By Service, 2021-2031, USD (Million)
        • 12.6.1.1.1. CRISPR And Cas Genes Market: By Application, 2021-2031, USD (Million)
        • 12.6.1.1.1. CRISPR And Cas Genes Market: By End-use, 2021-2031, USD (Million)
      • 12.6.1.2. Mexico
        • 12.6.1.2.1. CRISPR And Cas Genes Market: By Product, 2021-2031, USD (Million)
        • 12.6.1.2.1. CRISPR And Cas Genes Market: By Service, 2021-2031, USD (Million)
        • 12.6.1.2.1. CRISPR And Cas Genes Market: By Application, 2021-2031, USD (Million)
        • 12.6.1.2.1. CRISPR And Cas Genes Market: By End-use, 2021-2031, USD (Million)
      • 12.6.1.3. Rest of Latin America
        • 12.6.1.3.1. CRISPR And Cas Genes Market: By Product, 2021-2031, USD (Million)
        • 12.6.1.3.1. CRISPR And Cas Genes Market: By Service, 2021-2031, USD (Million)
        • 12.6.1.3.1. CRISPR And Cas Genes Market: By Application, 2021-2031, USD (Million)
        • 12.6.1.3.1. CRISPR And Cas Genes Market: By End-use, 2021-2031, USD (Million)

13. Middle East and Africa CRISPR And Cas Genes Market, 2021-2031, USD (Million)

  • 13.1. Market Overview
  • 13.2. CRISPR And Cas Genes Market: By Product, 2021-2031, USD (Million)
  • 13.3. CRISPR And Cas Genes Market: By Service, 2021-2031, USD (Million)
  • 13.4. CRISPR And Cas Genes Market: By Application, 2021-2031, USD (Million)
  • 13.5. CRISPR And Cas Genes Market: By End-use, 2021-2031, USD (Million)
  • 13.6.CRISPR And Cas Genes Market: By Region, 2021-2031, USD (Million)
    • 13.6.1.Middle East and Africa
      • 13.6.1.1. GCC
        • 13.6.1.1.1. CRISPR And Cas Genes Market: By Product, 2021-2031, USD (Million)
        • 13.6.1.1.1. CRISPR And Cas Genes Market: By Service, 2021-2031, USD (Million)
        • 13.6.1.1.1. CRISPR And Cas Genes Market: By Application, 2021-2031, USD (Million)
        • 13.6.1.1.1. CRISPR And Cas Genes Market: By End-use, 2021-2031, USD (Million)
      • 13.6.1.2. Africa
        • 13.6.1.2.1. CRISPR And Cas Genes Market: By Product, 2021-2031, USD (Million)
        • 13.6.1.2.1. CRISPR And Cas Genes Market: By Service, 2021-2031, USD (Million)
        • 13.6.1.2.1. CRISPR And Cas Genes Market: By Application, 2021-2031, USD (Million)
        • 13.6.1.2.1. CRISPR And Cas Genes Market: By End-use, 2021-2031, USD (Million)
      • 13.6.1.3. Rest of Middle East and Africa
        • 13.6.1.3.1. CRISPR And Cas Genes Market: By Product, 2021-2031, USD (Million)
        • 13.6.1.3.1. CRISPR And Cas Genes Market: By Service, 2021-2031, USD (Million)
        • 13.6.1.3.1. CRISPR And Cas Genes Market: By Application, 2021-2031, USD (Million)
        • 13.6.1.3.1. CRISPR And Cas Genes Market: By End-use, 2021-2031, USD (Million)

14. Company Profile

  • 14.1. Thermo Fisher Scientific, Inc.
    • 14.1.1. Company Overview
    • 14.1.2. Financial Performance
    • 14.1.3. Product Portfolio
    • 14.1.4. Strategic Initiatives
  • 14.2. Editas Medicine, Inc.
    • 14.2.1. Company Overview
    • 14.2.2. Financial Performance
    • 14.2.3. Product Portfolio
    • 14.2.4. Strategic Initiatives
  • 14.3. CRISPR Therapeutics AG
    • 14.3.1. Company Overview
    • 14.3.2. Financial Performance
    • 14.3.3. Product Portfolio
    • 14.3.4. Strategic Initiatives
  • 14.4. Intellia Therapeutics, Inc.
    • 14.4.1. Company Overview
    • 14.4.2. Financial Performance
    • 14.4.3. Product Portfolio
    • 14.4.4. Strategic Initiatives
  • 14.5. Caribou Biosciences, Inc.
    • 14.5.1. Company Overview
    • 14.5.2. Financial Performance
    • 14.5.3. Product Portfolio
    • 14.5.4. Strategic Initiatives
  • 14.6. Other Notable Players
    • 14.6.1. Company Overview
    • 14.6.2. Financial Performance
    • 14.6.3. Product Portfolio
    • 14.6.4. Strategic Initiatives

List of Tables

  • TABLE 1 Global CRISPR And Cas Genes Market By Product, 2021-2031, USD (Million)
  • TABLE 2 Global CRISPR And Cas Genes Market By Kits & Enzymes, 2021-2031, USD (Million)
  • TABLE 3 Global CRISPR And Cas Genes Market By Service, 2021-2031, USD (Million)
  • TABLE 4 Global CRISPR And Cas Genes Market By Application, 2021-2031, USD (Million)
  • TABLE 5 Global CRISPR And Cas Genes Market By Biomedical, 2021-2031, USD (Million)
  • TABLE 6 Global CRISPR And Cas Genes Market By End-use, 2021-2031, USD (Million)
  • TABLE 7 North America CRISPR And Cas Genes Market By Product, 2021-2031, USD (Million)
  • TABLE 8 North America CRISPR And Cas Genes Market By Kits & Enzymes, 2021-2031, USD (Million)
  • TABLE 9 North America CRISPR And Cas Genes Market By Service, 2021-2031, USD (Million)
  • TABLE 10 North America CRISPR And Cas Genes Market By Application, 2021-2031, USD (Million)
  • TABLE 11 North America CRISPR And Cas Genes Market By Biomedical, 2021-2031, USD (Million)
  • TABLE 12 North America CRISPR And Cas Genes Market By End-use, 2021-2031, USD (Million)
  • TABLE 13 U.S. CRISPR And Cas Genes Market By Product, 2021-2031, USD (Million)
  • TABLE 14 U.S. CRISPR And Cas Genes Market By Kits & Enzymes, 2021-2031, USD (Million)
  • TABLE 15 U.S. CRISPR And Cas Genes Market By Service, 2021-2031, USD (Million)
  • TABLE 16 U.S. CRISPR And Cas Genes Market By Application, 2021-2031, USD (Million)
  • TABLE 17 U.S. CRISPR And Cas Genes Market By Biomedical, 2021-2031, USD (Million)
  • TABLE 18 U.S. CRISPR And Cas Genes Market By End-use, 2021-2031, USD (Million)
  • TABLE 19 Canada CRISPR And Cas Genes Market By Product, 2021-2031, USD (Million)
  • TABLE 20 Canada CRISPR And Cas Genes Market By Kits & Enzymes, 2021-2031, USD (Million)
  • TABLE 21 Canada CRISPR And Cas Genes Market By Service, 2021-2031, USD (Million)
  • TABLE 22 Canada CRISPR And Cas Genes Market By Application, 2021-2031, USD (Million)
  • TABLE 23 Canada CRISPR And Cas Genes Market By Biomedical, 2021-2031, USD (Million)
  • TABLE 24 Canada CRISPR And Cas Genes Market By End-use, 2021-2031, USD (Million)
  • TABLE 25 Rest of North America CRISPR And Cas Genes Market By Product, 2021-2031, USD (Million)
  • TABLE 26 Rest of North America CRISPR And Cas Genes Market By Kits & Enzymes, 2021-2031, USD (Million)
  • TABLE 27 Rest of North America CRISPR And Cas Genes Market By Service, 2021-2031, USD (Million)
  • TABLE 28 Rest of North America CRISPR And Cas Genes Market By Application, 2021-2031, USD (Million)
  • TABLE 29 Rest of North America CRISPR And Cas Genes Market By Biomedical, 2021-2031, USD (Million)
  • TABLE 30 Rest of North America CRISPR And Cas Genes Market By End-use, 2021-2031, USD (Million)
  • TABLE 31 UK and European Union CRISPR And Cas Genes Market By Product, 2021-2031, USD (Million)
  • TABLE 32 UK and European Union CRISPR And Cas Genes Market By Kits & Enzymes, 2021-2031, USD (Million)
  • TABLE 33 UK and European Union CRISPR And Cas Genes Market By Service, 2021-2031, USD (Million)
  • TABLE 34 UK and European Union CRISPR And Cas Genes Market By Application, 2021-2031, USD (Million)
  • TABLE 35 UK and European Union CRISPR And Cas Genes Market By Biomedical, 2021-2031, USD (Million)
  • TABLE 36 UK and European Union CRISPR And Cas Genes Market By End-use, 2021-2031, USD (Million)
  • TABLE 37 UK CRISPR And Cas Genes Market By Product, 2021-2031, USD (Million)
  • TABLE 38 UK CRISPR And Cas Genes Market By Kits & Enzymes, 2021-2031, USD (Million)
  • TABLE 39 UK CRISPR And Cas Genes Market By Service, 2021-2031, USD (Million)
  • TABLE 40 UK CRISPR And Cas Genes Market By Application, 2021-2031, USD (Million)
  • TABLE 41 UK CRISPR And Cas Genes Market By Biomedical, 2021-2031, USD (Million)
  • TABLE 42 UK CRISPR And Cas Genes Market By End-use, 2021-2031, USD (Million)
  • TABLE 43 Germany CRISPR And Cas Genes Market By Product, 2021-2031, USD (Million)
  • TABLE 44 Germany CRISPR And Cas Genes Market By Kits & Enzymes, 2021-2031, USD (Million)
  • TABLE 45 Germany CRISPR And Cas Genes Market By Service, 2021-2031, USD (Million)
  • TABLE 46 Germany CRISPR And Cas Genes Market By Application, 2021-2031, USD (Million)
  • TABLE 47 Germany CRISPR And Cas Genes Market By Biomedical, 2021-2031, USD (Million)
  • TABLE 48 Germany CRISPR And Cas Genes Market By End-use, 2021-2031, USD (Million)
  • TABLE 49 Spain CRISPR And Cas Genes Market By Product, 2021-2031, USD (Million)
  • TABLE 50 Spain CRISPR And Cas Genes Market By Kits & Enzymes, 2021-2031, USD (Million)
  • TABLE 51 Spain CRISPR And Cas Genes Market By Service, 2021-2031, USD (Million)
  • TABLE 52 Spain CRISPR And Cas Genes Market By Application, 2021-2031, USD (Million)
  • TABLE 53 Spain CRISPR And Cas Genes Market By Biomedical, 2021-2031, USD (Million)
  • TABLE 54 Spain CRISPR And Cas Genes Market By End-use, 2021-2031, USD (Million)
  • TABLE 55 Italy CRISPR And Cas Genes Market By Product, 2021-2031, USD (Million)
  • TABLE 56 Italy CRISPR And Cas Genes Market By Kits & Enzymes, 2021-2031, USD (Million)
  • TABLE 57 Italy CRISPR And Cas Genes Market By Service, 2021-2031, USD (Million)
  • TABLE 58 Italy CRISPR And Cas Genes Market By Application, 2021-2031, USD (Million)
  • TABLE 59 Italy CRISPR And Cas Genes Market By Biomedical, 2021-2031, USD (Million)
  • TABLE 60 Italy CRISPR And Cas Genes Market By End-use, 2021-2031, USD (Million)
  • TABLE 61 France CRISPR And Cas Genes Market By Product, 2021-2031, USD (Million)
  • TABLE 62 France CRISPR And Cas Genes Market By Kits & Enzymes, 2021-2031, USD (Million)
  • TABLE 63 France CRISPR And Cas Genes Market By Service, 2021-2031, USD (Million)
  • TABLE 64 France CRISPR And Cas Genes Market By Application, 2021-2031, USD (Million)
  • TABLE 65 France CRISPR And Cas Genes Market By Biomedical, 2021-2031, USD (Million)
  • TABLE 66 France CRISPR And Cas Genes Market By End-use, 2021-2031, USD (Million)
  • TABLE 67 Rest of Europe CRISPR And Cas Genes Market By Product, 2021-2031, USD (Million)
  • TABLE 68 Rest of Europe CRISPR And Cas Genes Market By Kits & Enzymes, 2021-2031, USD (Million)
  • TABLE 69 Rest of Europe CRISPR And Cas Genes Market By Service, 2021-2031, USD (Million)
  • TABLE 70 Rest of Europe CRISPR And Cas Genes Market By Application, 2021-2031, USD (Million)
  • TABLE 71 Rest of Europe CRISPR And Cas Genes Market By Biomedical, 2021-2031, USD (Million)
  • TABLE 72 Rest of Europe CRISPR And Cas Genes Market By End-use, 2021-2031, USD (Million)
  • TABLE 73 Asia CRISPR And Cas Genes Market By Product, 2021-2031, USD (Million)
  • TABLE 74 Asia CRISPR And Cas Genes Market By Kits & Enzymes, 2021-2031, USD (Million)
  • TABLE 75 Asia CRISPR And Cas Genes Market By Service, 2021-2031, USD (Million)
  • TABLE 76 Asia CRISPR And Cas Genes Market By Application, 2021-2031, USD (Million)
  • TABLE 77 Asia CRISPR And Cas Genes Market By Biomedical, 2021-2031, USD (Million)
  • TABLE 78 Asia CRISPR And Cas Genes Market By End-use, 2021-2031, USD (Million)
  • TABLE 79 China CRISPR And Cas Genes Market By Product, 2021-2031, USD (Million)
  • TABLE 80 China CRISPR And Cas Genes Market By Kits & Enzymes, 2021-2031, USD (Million)
  • TABLE 81 China CRISPR And Cas Genes Market By Service, 2021-2031, USD (Million)
  • TABLE 82 China CRISPR And Cas Genes Market By Application, 2021-2031, USD (Million)
  • TABLE 83 China CRISPR And Cas Genes Market By Biomedical, 2021-2031, USD (Million)
  • TABLE 84 China CRISPR And Cas Genes Market By End-use, 2021-2031, USD (Million)
  • TABLE 85 Japan CRISPR And Cas Genes Market By Product, 2021-2031, USD (Million)
  • TABLE 86 Japan CRISPR And Cas Genes Market By Kits & Enzymes, 2021-2031, USD (Million)
  • TABLE 87 Japan CRISPR And Cas Genes Market By Service, 2021-2031, USD (Million)
  • TABLE 88 Japan CRISPR And Cas Genes Market By Application, 2021-2031, USD (Million)
  • TABLE 89 Japan CRISPR And Cas Genes Market By Biomedical, 2021-2031, USD (Million)
  • TABLE 90 Japan CRISPR And Cas Genes Market By End-use, 2021-2031, USD (Million)
  • TABLE 91 India CRISPR And Cas Genes Market By Product, 2021-2031, USD (Million)
  • TABLE 92 India CRISPR And Cas Genes Market By Kits & Enzymes, 2021-2031, USD (Million)
  • TABLE 93 India CRISPR And Cas Genes Market By Service, 2021-2031, USD (Million)
  • TABLE 94 India CRISPR And Cas Genes Market By Application, 2021-2031, USD (Million)
  • TABLE 95 India CRISPR And Cas Genes Market By Biomedical, 2021-2031, USD (Million)
  • TABLE 96 India CRISPR And Cas Genes Market By End-use, 2021-2031, USD (Million)
  • TABLE 97 Australia CRISPR And Cas Genes Market By Product, 2021-2031, USD (Million)
  • TABLE 98 Australia CRISPR And Cas Genes Market By Kits & Enzymes, 2021-2031, USD (Million)
  • TABLE 99 Australia CRISPR And Cas Genes Market By Service, 2021-2031, USD (Million)
  • TABLE 100 Australia CRISPR And Cas Genes Market By Application, 2021-2031, USD (Million)
  • TABLE 101 Australia CRISPR And Cas Genes Market By Biomedical, 2021-2031, USD (Million)
  • TABLE 102 Australia CRISPR And Cas Genes Market By End-use, 2021-2031, USD (Million)
  • TABLE 103 South Korea CRISPR And Cas Genes Market By Product, 2021-2031, USD (Million)
  • TABLE 104 South Korea CRISPR And Cas Genes Market By Kits & Enzymes, 2021-2031, USD (Million)
  • TABLE 105 South Korea CRISPR And Cas Genes Market By Service, 2021-2031, USD (Million)
  • TABLE 106 South Korea CRISPR And Cas Genes Market By Application, 2021-2031, USD (Million)
  • TABLE 107 South Korea CRISPR And Cas Genes Market By Biomedical, 2021-2031, USD (Million)
  • TABLE 108 South Korea CRISPR And Cas Genes Market By End-use, 2021-2031, USD (Million)
  • TABLE 109 Latin America CRISPR And Cas Genes Market By Product, 2021-2031, USD (Million)
  • TABLE 110 Latin America CRISPR And Cas Genes Market By Kits & Enzymes, 2021-2031, USD (Million)
  • TABLE 111 Latin America CRISPR And Cas Genes Market By Service, 2021-2031, USD (Million)
  • TABLE 112 Latin America CRISPR And Cas Genes Market By Application, 2021-2031, USD (Million)
  • TABLE 113 Latin America CRISPR And Cas Genes Market By Biomedical, 2021-2031, USD (Million)
  • TABLE 114 Latin America CRISPR And Cas Genes Market By End-use, 2021-2031, USD (Million)
  • TABLE 115 Brazil CRISPR And Cas Genes Market By Product, 2021-2031, USD (Million)
  • TABLE 116 Brazil CRISPR And Cas Genes Market By Kits & Enzymes, 2021-2031, USD (Million)
  • TABLE 117 Brazil CRISPR And Cas Genes Market By Service, 2021-2031, USD (Million)
  • TABLE 118 Brazil CRISPR And Cas Genes Market By Application, 2021-2031, USD (Million)
  • TABLE 119 Brazil CRISPR And Cas Genes Market By Biomedical, 2021-2031, USD (Million)
  • TABLE 120 Brazil CRISPR And Cas Genes Market By End-use, 2021-2031, USD (Million)
  • TABLE 121 Mexico CRISPR And Cas Genes Market By Product, 2021-2031, USD (Million)
  • TABLE 122 Mexico CRISPR And Cas Genes Market By Kits & Enzymes, 2021-2031, USD (Million)
  • TABLE 123 Mexico CRISPR And Cas Genes Market By Service, 2021-2031, USD (Million)
  • TABLE 124 Mexico CRISPR And Cas Genes Market By Application, 2021-2031, USD (Million)
  • TABLE 125 Mexico CRISPR And Cas Genes Market By Biomedical, 2021-2031, USD (Million)
  • TABLE 126 Mexico CRISPR And Cas Genes Market By End-use, 2021-2031, USD (Million)
  • TABLE 127 Rest of Latin America CRISPR And Cas Genes Market By Product, 2021-2031, USD (Million)
  • TABLE 128 Rest of Latin America CRISPR And Cas Genes Market By Kits & Enzymes, 2021-2031, USD (Million)
  • TABLE 129 Rest of Latin America CRISPR And Cas Genes Market By Service, 2021-2031, USD (Million)
  • TABLE 130 Rest of Latin America CRISPR And Cas Genes Market By Application, 2021-2031, USD (Million)
  • TABLE 131 Rest of Latin America CRISPR And Cas Genes Market By Biomedical, 2021-2031, USD (Million)
  • TABLE 132 Rest of Latin America CRISPR And Cas Genes Market By End-use, 2021-2031, USD (Million)
  • TABLE 133 Middle East and Africa CRISPR And Cas Genes Market By Product, 2021-2031, USD (Million)
  • TABLE 134 Middle East and Africa CRISPR And Cas Genes Market By Kits & Enzymes, 2021-2031, USD (Million)
  • TABLE 135 Middle East and Africa CRISPR And Cas Genes Market By Service, 2021-2031, USD (Million)
  • TABLE 136 Middle East and Africa CRISPR And Cas Genes Market By Application, 2021-2031, USD (Million)
  • TABLE 137 Middle East and Africa CRISPR And Cas Genes Market By Biomedical, 2021-2031, USD (Million)
  • TABLE 138 Middle East and Africa CRISPR And Cas Genes Market By End-use, 2021-2031, USD (Million)
  • TABLE 139 GCC CRISPR And Cas Genes Market By Product, 2021-2031, USD (Million)
  • TABLE 140 GCC CRISPR And Cas Genes Market By Kits & Enzymes, 2021-2031, USD (Million)
  • TABLE 141 GCC CRISPR And Cas Genes Market By Service, 2021-2031, USD (Million)
  • TABLE 142 GCC CRISPR And Cas Genes Market By Application, 2021-2031, USD (Million)
  • TABLE 143 GCC CRISPR And Cas Genes Market By Biomedical, 2021-2031, USD (Million)
  • TABLE 144 GCC CRISPR And Cas Genes Market By End-use, 2021-2031, USD (Million)
  • TABLE 145 Africa CRISPR And Cas Genes Market By Product, 2021-2031, USD (Million)
  • TABLE 146 Africa CRISPR And Cas Genes Market By Kits & Enzymes, 2021-2031, USD (Million)
  • TABLE 147 Africa CRISPR And Cas Genes Market By Service, 2021-2031, USD (Million)
  • TABLE 148 Africa CRISPR And Cas Genes Market By Application, 2021-2031, USD (Million)
  • TABLE 149 Africa CRISPR And Cas Genes Market By Biomedical, 2021-2031, USD (Million)
  • TABLE 150 Africa CRISPR And Cas Genes Market By End-use, 2021-2031, USD (Million)
  • TABLE 151 Rest of Middle East and Africa CRISPR And Cas Genes Market By Product, 2021-2031, USD (Million)
  • TABLE 152 Rest of Middle East and Africa CRISPR And Cas Genes Market By Kits & Enzymes, 2021-2031, USD (Million)
  • TABLE 153 Rest of Middle East and Africa CRISPR And Cas Genes Market By Service, 2021-2031, USD (Million)
  • TABLE 154 Rest of Middle East and Africa CRISPR And Cas Genes Market By Application, 2021-2031, USD (Million)
  • TABLE 155 Rest of Middle East and Africa CRISPR And Cas Genes Market By Biomedical, 2021-2031, USD (Million)
  • TABLE 156 Rest of Middle East and Africa CRISPR And Cas Genes Market By End-use, 2021-2031, USD (Million)

List of Figures

  • FIG. 1 Global CRISPR And Cas Genes Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global CRISPR And Cas Genes Market: Quality Assurance
  • FIG. 5 Global CRISPR And Cas Genes Market, By Product, 2022
  • FIG. 6 Global CRISPR And Cas Genes Market, By Service, 2022
  • FIG. 7 Global CRISPR And Cas Genes Market, By Application, 2022
  • FIG. 8 Global CRISPR And Cas Genes Market, By End-use, 2022
  • FIG. 9 Global CRISPR And Cas Genes Market, By Geography, 2022
  • FIG. 10 Market Geographical Opportunity Matrix - Global CRISPR And Cas Genes Market, 2022
  • FIG. 11 Market Positioning of Key CRISPR And Cas Genes Market Players, 2022
  • FIG. 12 Global CRISPR And Cas Genes Market - Tier Analysis - Percentage of Revenues by Tier Level, 2022 Versus 2031
  • FIG. 13 Global CRISPR And Cas Genes Market, By Product, 2022 Vs 2031, %
  • FIG. 14 Global CRISPR And Cas Genes Market, By Service, 2022 Vs 2031, %
  • FIG. 15 Global CRISPR And Cas Genes Market, By Application, 2022 Vs 2031, %
  • FIG. 16 Global CRISPR And Cas Genes Market, By End-use, 2022 Vs 2031, %
  • FIG. 17 U.S. CRISPR And Cas Genes Market (US$ Million), 2021 - 2031
  • FIG. 18 Canada CRISPR And Cas Genes Market (US$ Million), 2021 - 2031
  • FIG. 19 Rest of North America CRISPR And Cas Genes Market (US$ Million), 2021 - 2031
  • FIG. 20 UK CRISPR And Cas Genes Market (US$ Million), 2021 - 2031
  • FIG. 21 Germany CRISPR And Cas Genes Market (US$ Million), 2021 - 2031
  • FIG. 22 Spain CRISPR And Cas Genes Market (US$ Million), 2021 - 2031
  • FIG. 23 Italy CRISPR And Cas Genes Market (US$ Million), 2021 - 2031
  • FIG. 24 France CRISPR And Cas Genes Market (US$ Million), 2021 - 2031
  • FIG. 25 Rest of Europe CRISPR And Cas Genes Market (US$ Million), 2021 - 2031
  • FIG. 26 China CRISPR And Cas Genes Market (US$ Million), 2021 - 2031
  • FIG. 27 Japan CRISPR And Cas Genes Market (US$ Million), 2021 - 2031
  • FIG. 28 India CRISPR And Cas Genes Market (US$ Million), 2021 - 2031
  • FIG. 29 Australia CRISPR And Cas Genes Market (US$ Million), 2021 - 2031
  • FIG. 30 South Korea CRISPR And Cas Genes Market (US$ Million), 2021 - 2031
  • FIG. 31 Rest of Asia CRISPR And Cas Genes Market (US$ Million), 2021 - 2031
  • FIG. 32 Brazil CRISPR And Cas Genes Market (US$ Million), 2021 - 2031
  • FIG. 33 Mexico CRISPR And Cas Genes Market (US$ Million), 2021 - 2031
  • FIG. 34 Rest of Latin America CRISPR And Cas Genes Market (US$ Million), 2021 - 2031
  • FIG. 35 GCC CRISPR And Cas Genes Market (US$ Million), 2021 - 2031
  • FIG. 36 Africa CRISPR And Cas Genes Market (US$ Million), 2021 - 2031
  • FIG. 37 Rest of Middle East and Africa CRISPR And Cas Genes Market (US$ Million), 2021 - 2031